Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
JM

Jacques Mallet — 23 Patents

ASAventis Pharma S.A.: 12 patents #20 of 591Top 4%
CNCNRS: 5 patents #412 of 11,908Top 4%
RSRhone-Poulenc Rorer S.A.: 4 patents #57 of 323Top 20%
A(Assistance Publique—Hôpitaux De Paris (Aphp): 1 patents #300 of 877Top 35%
SUSorbonne Universite: 1 patents #147 of 655Top 25%
SASanofi-Aventis: 1 patents #285 of 563Top 55%
Paris, FR: #231 of 13,709 inventorsTop 2%
Overall (All Time): #178,160 of 4,157,543Top 5%
23 Patents All Time
Jacques Mallet has been granted 23 US patents while listed as an inventor at Aventis Pharma S.A.. The first was granted in 1997 and the most recent in September 2025. Jacques Mallet ranks #178,160 of 4,157,543 US inventors in our database (top 4.3%). Patent records list Jacques Mallet in Paris, FR.

Issued Patents All Time

Showing 1–23 of 23 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12419971 Diet controlled expression of a nucleic acid encoding a pro-apoptotic protein Pierre FAFOURNOUX 2025-09-23
8431119 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases Frederic Revah, Jean-Marie Stutzmann 2013-04-30
8119119 Non-integrative and non-replicative lentivirus, preparation and uses thereof Che Serguera, Stephanie Philippe, Chamsy Sarkis 2012-02-21
8071753 RNAi mediated expression inhibition of a cholinergic protein Sylvie Berrard, Marie José Lecomte, Julie Santamaria 2011-12-06
7749973 Methods of gene transfer to astrocytes with mokola virus pseudotyped lentivirus vectors Chamsy Sarkis, Yi He, Che Serguera, Noelle Dufour 2010-07-06
7341718 Neuronal gene transfer of adenovirus and herpes virus vectors Stéphanie Millecamps-Navarro, Martine Barkats 2008-03-11
7273854 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative disorders Frederic Revah, Jean-Marie Stutzmann 2007-09-25 $34,719,000
7241591 Adenovirus comprising a gene coding for glutathione peroxidase Martine Barkats, Frederic Revah 2007-07-10
7018628 Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates Chamsy Sarkis 2006-03-28
6998474 Polypeptides of the “basic helix-loop-helix” bHLH family, corresponding nucleic acid sequences Christine Icard-Liepkalns, Philippe Ravassard 2006-02-14
6943016 Human adult astrocytes, their preparation and uses thereof Jean-Luc Ridet 2005-09-13
6756523 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain Axel Kahn, Gildas Le Gal La Salle, Michel Perricaudet, Marc Peschanski, Jean-Jacques Robert 2004-06-29 $5,971,000
6723315 Method for treating amyotrophic lateral sclerosis Philippe Kennel, Frederic Revah, Axel Kahn, Georg Haase 2004-04-20 $4,804,000
6685934 Recombinant adenoviruses coding for basic fibroblast growth factors (BFGF) Michel Perricaudet, Emmanuelle Vigne, Frederic Revah, Marc Abitbol, Paul Roustan 2004-02-03 $2,721,000
6632427 Adenoviral-vector-mediated gene transfer into medullary motor neurons Françoise Finiels, Minerva Gimenez-Ribotta, Alain Privat, Frederic Revah 2003-10-14 $2,614,000
6552003 Muscle reinnervation and motor axon sprouting by administering DNA sequences encoding NT-3 and CNTF Françoise Finiels, Minerva Gimenez-Ribotta, Alain Privat, Frederic Revah 2003-04-22 $2,807,000
6458529 Assays for promoter operability in central nervous system cells Axel Kahn, Gildas Le Gal La Salle, Michel Perricaudet, Marc Peschanski, Jean-Jacques Robert 2002-10-01 $3,987,000
6432701 Derived tyrosine hydroxylase gene expression system Rolando Meloni, Philippe Ravassard, Fabienne Treilhou 2002-08-13 $954,000
6245330 Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF) Philippe Horellou, Michel Perricaudet, Frederic Revah, Emmanuelle Vigne 2001-06-12 $5,503,000
6235497 Recombinant expression of the rat vesicular acetylcholine transporter Stephane Bejanin, Sylvie Berrard, Riccardo Cervini 2001-05-22
6210879 Method for diagnosing schizophrenia Rolando Meloni, Claudine Laurent 2001-04-03
6140112 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases Frederic Revah, Jean-Jacques Robert 2000-10-31
5648259 Polypeptides having NMDA receptor activity, nucleic acids encoding those polypeptides and applications Tania Smirnova 1997-07-15 $37,829,000